Epidemiology of HIV infection in the middle east and North Africa

AIDS

Volumn 24, Issue SUPPL. 2, 2010, Pages

  Abu Raddad, Laith J ^a,b,c   Hilmi, Nahla ^d   Mumtaz, Ghina ^a   Benkirane, Manal ^e   Akala, Francisca Ayodeji ^d   Riedner, Gabriele ^f   Tawil, Oussama ^g   Wilson, David ^d  

^a Department of Obstetrics Gynecology   (Qatar)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d WORLD BANK   (United States)

^e Association de Lutte Contre le Sida   (Morocco)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

^g Middle East and North Africa   (Egypt)

Author keywords

AIDS; epidemiology; HIV; Middle East and North Africa; review

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CIRCUMCISION; EPIDEMIC; EPIDEMIOLOGICAL DATA; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE HOMOSEXUAL; MIDDLE EAST; NORTH AFRICA; PRIORITY JOURNAL; PROSTITUTION; REVIEW; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; STIGMA; SUDAN; SYSTEMATIC REVIEW; TRAVEL; VIRUS TRANSMISSION;

AFRICA, NORTHERN; DISEASE OUTBREAKS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE EAST; POPULATION SURVEILLANCE; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES; SOCIOECONOMIC FACTORS;

EID: 77954602423     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/01.aids.0000386729.56683.33     Document Type: Review

References (305)

1. Obermeyer CM. HIV in the Middle East. BMJ 2006; 333:851-854.
2. Abu-Raddad L, Akala FA, Semini I, Riedner G, Wilson D, Tawil O, et al. Characterizing the HIV/AIDS epidemic in the Middle East and North Africa: Time for Strategic Action. Middle East and North Africa HIV/AIDS Epidemiology Synthesis Project. World Bank/UNAIDS/WHO; 2010.
3. Bohannon J. Science in Libya. From pariah to science powerhouse? Science 2005; 308:182-184.
4. Gray PB. HIV and Islam: is HIV prevalence lower among Muslims? Soc Sci Med 2004; 58:1751-1756.
5. Khawaja ZA, Gibney L, Ahmed AJ, Vermund SH. HIV/AIDS and its risk factors in Pakistan. AIDS 1997; 11:843-848.
6. Lenton C. Will Egypt escape the AIDS epidemic? Lancet 1997; 349:1005.
7. Kelley L, Eberstadt N. Behind the veil of a public health crisis: HIV/AIDS in the Muslim world. NBR Special Report 2005.
8. Kelley LM, Eberstadt N. The Muslim face of AIDS. Foreign Policy 2005; 149:42-48.
9. Carael M, Cleland J, Adeokun L. Overview and selected findings of sexual behaviour surveys. AIDS 1991; 5 (Suppl 1): S65-S74.
10. Busulwa R. HIV/AIDS Situation Analysis study, conducted in Hodeidah, Taiz and Hadhramut, Republic of Yemen. The Detailed Report of the Findings. 2003.
11. Mohammad K,Farahani FK, Mohammadi MR, Alikhani S,Zare M, Tehrani FR, et al. Sexual risk-taking behaviors among boys aged 15-18 years in Tehran. J Adolesc Health 2007; 41:407-414.
12. Abukhalil A. Gender boundaries and sexual categories in the Arab world. Fem Issues 1997; 15:91-104.
13. UNAIDS RST MENA. Notes on AIDS in the Middle East and North Africa. 2008.
14. Roudi-Fahimi F, Ashford L. Sexual & Reproductive Health in the Middle East and North Africa. Population Reference Bureau. A Guide for Reporters. 2008
15. UNAIDS/UNHCR. Strategies to support the HIV related needs of refugees and host populations. Geneva: UNAIDS/UNHRC; 2005.
16. UNODC. United Nations Office on Drugs and Crime (2007). World Drug Report. 2007.
17. Shaar AN, Larenas J. Social Determinants of Health. Palestine Country Paper. Geneva: World Health Organization; 2005.
18. UNAIDS/WHO. AIDS epidemic update 2003. Geneva: UNAIDS/WHO 2003.
19. Iran Center for Disease Management MoHaME. AIDS/HIV Surveillance Report. 2005.
20. UNAIDS/WHO. AIDS epidemic update 2001. 2001.
21. UNAIDS/WHO. AIDS epidemic update 2002. 2002.
22. SAR AIDS, The World Bank. Mapping and Situation Assessment of Key Populations at High Risk of HIV in Three Cities of Afghanistan. Human Development Sector, South Asia Region, The World Bank; 2008.
23. Sanders-Buell E, Saad MD, Abed AM, Bose M, Todd CS, Strathdee SA, et al. A nascent HIV type 1 epidemic among injecting drug users in Kabul, Afghanistan is dominated by complex AD recombinant strain, CRF35-AD. AIDS Res Hum Retroviruses 2007; 23:834-839.
24. Todd CS, Abed AM, Strathdee SA, Scott PT, Botros BA, Safi N, et al. HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan. Emerg Infect Dis 2007; 13:1327-1331.
25. Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008; 372:1733-1745.
26. Mimouni B, Remaoun N. Ministry of Higher Education, Algeria. Etude du Lien Potentiel entre l'Usage Problématique de Drogues et le VIH/SIDA en Algérie 2004-2005. 2006.
27. Rapport de l'enquête nationale de séro-surveillance sentinelle du VIH et de la syphilis en Algérie 2004-2005. unknown.
28. Fares G, et al. Rapport sur l'enquête nationale de sero-surveil-lance sentinelle du VIH et de la syphilis en Algérie en 2004. Décembre. Ministère de la Santé de la population et de la reforme hospitalière. Alger; 2004.
29. Institut de Formation Paramédicale de Parnet Rapport de la réunion d'évaluation a mis-parcours de l'enquête de sero-surveillance du VIH. Juin 2004.
30. Alami K. Tendances récentes de l'épidémie à VIH/SIDA en Afrique du nord. Presentation. Research and AIDS Workshop in North Africa/Marrakech, Morocco; 2009
31. Statut de la réponse nationale. Caractéristiques de l'épidémie des IST/VIH/SIDA. Algeria. unknown.
32. Aceijas C, Stimson GV, Hickman M, Rhodes T. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 2004; 18:2295-2303. (Pubitemid 39620222)
33. Al-Haddad MK, Khashaba AS, Baig BZ, Khalfan S. HIV antibodies among intravenous drug users in Bahrain. J Commun Dis 1994; 26:127-132.
34. Fox E, Haberberger RL Jr, Abbatte EA, Said S, Polycarpe D, Constantine NT. Observations on sexually transmitted diseases in promiscuous males in Djibouti. J Egypt Public Health Assoc 1989; 64:561-569.
35. Philippon M, Saada M, Kamil MA, Houmed HM. Attendance at a health center by clandestine prostitutes in Djibouti. Sante 1997; 7:5-10.
36. Etchepare M. Programme National de Lutte contre le SIDA et les MST Draft report. Djibouti: World Bank Mission for Health Project Strategy Development; 2001.
37. Rodier GR, Couzineau B, Gray GC, Omar CS, Fox E, Bouloumie J, et al. Trends of human immunodeficiency virus type-1 infection in female prostitutes and males diagnosed with a sexually transmitted disease in Djibouti, east Africa. Am J Trop Med Hyg 1993; 48:682-686.
38. Marcelin AG, Grandadam M, Flandre P, Koeck JL, Philippon M, Nicand E, et al. Comparative study of heterosexual transmission of HIV-1, HSV-2 and KSHV in Djibouti. 8th Retrovir Oppor Infect (abstract no. 585); 2001.
39. Marcelin AG, Grandadam M, Flandre P, Nicand E, Milliancourt C, Koeck JL, et al. Kaposi's sarcoma herpesvirus and HIV-1 seroprevalences in prostitutes in Djibouti. J Med Virol 2002; 68:164-167.
40. El-Ghazzawi E, Hunsmann G, Schneider J. Low prevalence of antibodies to HIV-1 and HTLV-I in Alexandria, Egypt. AIDS Forsch 1987; 2:639.
41. Baqi S, Nabi N, Hasan SN, Khan AJ, Pasha O, Kayani N, et al. HIV antibody seroprevalence and associated risk factors in sex workers, drug users, and prisoners in Sindh, Pakistan. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18:73-79.
42. Saleh E, McFarland W, Rutherford G, Mandel J, El-Shazaly M, Coates T. Sentinel surveillance for HIV and markers for high risk behaviors among STD clinic attendees in Alexandria, Egypt. XIII International AIDS Conference; Durban, South Africa; 2000; poster MoPeC2398.
43. El-Ghazzawi E, Drew L, Hamdy L, El-Sherbini E, Sadek Sel D, Saleh E. Intravenous drug addicts: a high risk group for infection with human immunodeficiency virus, hepatitis viruses, cytomegalo virus and bacterial infections in Alexandria Egypt. J Egypt Public Health Assoc 1995; 70:127-150.
44. Watts DM, Constantine NT, Sheba MF, Kamal M, Callahan JD, Kilpatrick ME. Prevalence of HIV infection and AIDS in Egypt over four years of surveillance (1986-1990). J Trop Med Hyg 1993; 96:113-117
45. Egypt Ministry of Health and Population National AIDS Program. HIV/AIDS biological and behavioral surveillance survey. Summary Report Egypt; 2006.
46. El-RahmanA. Risky behaviours for HIV/AIDS infection among a sample of homosexuals in Cairo city, Egypt. XV International AIDS Conference; Bangkok; 11-16 July 2004; abstract WePeC6146.
47. Family Health International. Middle East and North Africa region final report, March 2005-June 2007. USAID's implementing AIDS prevention and care (IMPACT) project; 2007.
48. El-Sayyed N, Kabbash IA, El-Gueniedy M. Risk behaviours for HIV/AIDS infection among men who have sex with men in Cairo, Egypt. East Mediterr Health J 2008; 14:905-915.
49. Khani M, Vakili MM. Prevalence and risk factors of HIV, hepatitis B virus, and hepatitis C virus infections in drug addicts among Zanjan prisoners. Arch Iranian Med 2003; 6:1-4.
50. Iran Ministry of Health Iran. AIDS/HIV Surveillance Report, Fourth Quarter. Teheran: Ministry of Health 2004.
51. Zamani S, Kihara M, Gouya MM, Vazirian M, Ono-Kihara M, Razzaghi EM, et al. Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran. AIDS 2005; 19:709-716.
52. Zamani S, Kihara M, Gouya MM, Vazirian M, Nassirimanesh B, Ono-Kihara M, et al. High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran. J Acquir Immune Defic Syndr 2006; 42:342-346.
53. Mojtahedzadeh V, Razani N, Malekinejad M, Vazirian M, Shoaee S, Saberi Zafarghandi MB, et al. Injection drug use in Rural Iran: integrating HIV prevention into iran's rural primary healthcare system. AIDS Behav 2008; 12:S7-S12.
54. Rahbar AR, Rooholamini S, Khoshnood K. Prevalence of HIV infection and other blood-borne infections in incarcerated and nonincarcerated injection drug users (IDUs) in Mashhad, Iran. Int J Drug Policy 2004; 15:151-155.
55. Farhoudi B, Montevalian A, Motamedi M, Khameneh MM, Mohraz M, Rassolinejad M, et al. Human immunodeficiency virus and HIV-associated tuberculosis infection and their risk factors in injecting drug users in prison in Iran. 2003.
56. Jahani MR, KheirandishP,HosseiniM,ShirzadH,Seyedalinaghi SA, Karami N, et al. HIV seroconversion among injection drug users in detention, Tehran, Iran. AIDS 2009; 23:538-540.
57. Nassirimanesh B. Proceedings of the abstract for the Fourth National Harm Reduction Conference; Seattle, USA; 2002.
58. Talaie H, Shadnia SH, Okazi A, Pajouhmand A, Hasanian H, Arianpoor H. The prevalence of hepatitis B, hepatitis C and HIV infections in non-IV drug opioid poisoned patients in Tehran-Iran. Pak J Biol Sci 2007; 10:220-224.
59. Alizadeh AH, Alavian SM, Jafari K, Yazdi N. Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan-Iran. World J Gastroenterol 2005; 11:4085-4089.
60. Jahani MR, Alavian SM, Shirzad H, Kabir A, Hajarizadeh B. Distribution and risk factors of hepatitis B, hepatitis C, and HIV infection in a female population with "illegal social behaviour''. Sex Transm Infect 2005; 81:185.
61. WHO/EMRO. Regional database on HIV/AIDS. WHO Regional Office for the Eastern Mediterranean Mishwar. An integrated bio-behavioral surveillance study among four vulnerable groups in lebanon: men who have sex with men; prisoners; commercial sex workers and intravenous drug users. Final report; November 2008.
62. UNAIDS W. Epidemiological Fact Sheet on HIV/AIDS and Sexually Transmitted Infections, 2002 update, Libya. Geneva: UNAIDS, WHO; 2002.
63. Groterah A. Drug Abuse and HIV/AIDS in the Middle East and North Africa. A Situation Assessment. Internal document. 2002.
64. Tawilah J, Tawil O. Visit to Sultane of Oman. Travel Report Summary. National AIDS Programme at the Ministry of Health in Muscat and Salalah and WHO Representative Office. World Health Organization. Regional Office for the Eastern Mediterranean; 2001.
65. Ministry of Health. HIV Risk among Heroin and Injecting Drug Users in Muscat, Oman. Quantitative Survey. Preliminary Data. 2006.
66. Morocco Ministry of Health. Surveillance sentinelle du VIH, résultats 2006 et tendances de la séroprévalence du VIH. 2007.
67. Khattabi H, Alami K. Surveillance sentinelle du VIH, Résultats 2004 et tendance de la séroprévalence du VIH. Ministry of health. Morocco: UNAIDS; 2005.
68. Ministère de la Santé Maroc. Bulletin é pidemiologique de surveillance du VIH/SIDA et des infections sexuellement trans-missibles. Rabat, Ministère de la Santé Maroc. 2003/2004.
69. Ministère de la Santé Maroc. Bulletin é pidemiologique de surveillance du VIH/SIDA et des infections sexuellement trans-missibles. Rabat, Ministère de la Santé Maroc. 2005.
70. Iqbal J, Rehan N. Sero-prevalence of HIV: six years' experience at Shaikh Zayed Hospital, Lahore. J Pak Med Assoc 1996; 46:255-258.
71. Kuo I, ul-Hasan S, Galai N, Thomas DL, Zafar T, Ahmed MA, et al. High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan. Harm Reduct J 2006; 3:26.
72. Platt L, Vickerman P, Collumbien M, Hasan S, Lalji N, Mayhew S, et al. Prevalence of HIV, HCV and sexually transmitted infections among injecting drug users in Rawalpindi and Abbot-tabad, Pakistan: evidence for an emerging injection-related HIV epidemic. Sex Transm Infect 2009; 85 (Suppl 2): ii17-ii22.
73. Parviz S, Fatmi Z, Altaf A, McCormick JB, Fischer-Hoch S, Rahbar M, et al. Background demographics and risk behaviors of injecting drug users in Karachi, Pakistan. Int J Infect Dis 2006; 10:364-371.
74. Bokhari A, Nizamani NM, Jackson DJ, Rehan NE, Rahman M, Muzaffar R, et al. HIV risk in Karachi and Lahore, Pakistan: an emerging epidemic in injecting and commercial sex networks. Int J STD AIDS 2007; 18:486-492.
75. Altaf A, Memon A, Rehman N, Shah S. Harm reduction among injection drug users in Karachi, Pakistan. International AIDS Conference 2004. Bangkok; 2004; abstract WePeC5992.
76. Shah SA, Altaf A, Mujeeb SA, Memon A. An outbreak of HIV infection among injection drug users in a small town in Pakistan: potential for national implications. Int J STD AIDS 2004; 15:209
77. Sindh AIDS Control Program. Surveillance data. Pakistan: Government of Sindh; 2004.
78. Ur Rehman N, Emmanuel F, Akhtar S. HIV transmission among drug users in Larkana, Pakistan. Trop Doct 2007; 37:58-59
79. Pakistan National AIDS Control Program. HIV Second Generation Surveillance In Pakistan. National Report Round 1. National AIDS Control Program, Ministry Of Health, Pakistan. Canada-Pakistan HIV/AIDS Surveillance Project; 2005.
80. Pakistan National AIDS Control Program. HIV Second Generation Surveillance In Pakistan. National Report Round II. National AIDS Control Program, Ministry Of Health, Pakistan. Canada-Pakistan HIV/AIDS Surveillance Project; 2006.
81. Pakistan National AIDS Control Program. HIV Second Generation Surveillance In Pakistan. National Report Round III. National AIDS Control Program, Ministry Of Health, Pakistan. Canada-Pakistan HIV/AIDS Surveillance Project; 2008.
82. UNAIDS/WHO. AIDS epidemic update 2005. Geneva: WHO 2005.
83. Rai MA, Warraich HJ, Ali SH, Nerurkar VR. HIV/AIDS in Pakistan: the battle begins. Retrovirology 2007; 4:22.
84. Achakzai M, Kassi M, Kasi PM. Seroprevalences and co-infections of HIV, hepatitis C virus and hepatitis B virus in injecting drug users in Quetta, Pakistan. Trop Doct 2007; 37:43-45.
85. Pakistan National AIDS Control Programme. Pilot Study in Karachi & Rawalpindi. Ministry of Health, Government of Pakistan and Canada-Pakistan HIV/AIDS Surveillance Project. Integrated Behavioral and Biological Surveillance 2004.
86. Hawkes S, Collumbien M, Platt L, Lalji N, Rizvi N, Andreasen A, et al. HIV and other sexually transmitted infections among men, transgenders and women selling sex in two cities in Pakistan: a cross-sectional prevalence survey. Sex Transm Infect 2009; 85 (Suppl 2):ii8-ii16.
87. Baqi S, Shah SA, Baig MA, Mujeeb SA, Memon A. Seropre-valence of HIV, HBV, and syphilis and associated risk behaviours in male transvestites (Hijras) in Karachi, Pakistan. Int J STD AIDS 1999; 10:300-304.
88. Khan AA, Rehan N, Qayyum K, Khan A. Correlates and prevalence of HIV and sexually transmitted infections among Hijras (male transgenders) in Pakistan. Int J STD AIDS 2008; 19:817-820.
89. UNFPA. UNFPA survey among female sex workers in Karachi. Report found on Kaisernetwork Daily News (Jan 07 2009) under title 'UNFPA, Local NGO Partner for HIV Education Efforts Aimed at Pakistani Sex Workers' 2009.
90. Njoh J, Zimmo S. Prevalence of antibodies to hepatitis C virus in drug-dependent patients in Jeddah, Saudi Arabia. East Afr Med J 1997; 74:89-91.
91. Jama H, Grillner L, Biberfeld G, Osman S, Isse A, Abdirahman M, et al. Sexually transmitted viral infections in various population groups in Mogadishu, Somalia. Genitourin Med 1987; 63:329-332.
92. Burans JP, Fox E, Omar MA, Farah AH, Abbass S, Yusef S, et al. HIV infection surveillance in Mogadishu, Somalia. East Afr Med J 1990; 67:466-472.
93. Corwin AL, Olson JG, Omar MA, Razaki A, Watts DM. HIV-1 in Somalia: prevalence and knowledge among prostitutes. Aids 1991; 5:902-904.
94. Ahmed HJ, Omar K, Adan SY, Guled AM, Grillner L, Bygde-man S. Syphilis and human immunodeficiency virus serocon-version during a 6-month follow-up of female prostitutes in Mogadishu, Somalia. Int J STD AIDS 1991; 2:119-123.
95. Watts DM, Corwin AL, Omar MA, Hyams KC. Low risk of sexual transmission of hepatitis C virus in Somalia. Trans R Soc Trop Med Hyg 1994; 88:55-56.
96. Testa AC, Kriitmaa K. HIV and Syphilis Bio-Behavioural Surveillance Survey (BSS\+) Among Female Transactional Sex Workers in Hargeisa, Somaliland. International Organization for Migration. Geneva: World Health Organization; 2009.
97. Elrashied S. Draft Report: Generating Strategic Information and Assessing HIV/AIDS Knowledge, Attitude and Behaviour and Practices as well as Prevalence of HIV 1 among MSM in Khartoum State, 2005. Khartoum; 2006.
98. Basha HM. Vulnerable Population Research in Darfur. 2006 Anonymous. Improving HIV/AIDS Response among Most at Risk Population in Sudan. Orientation Workshop; 16 April 2007.
99. Ahmed SM. Sex sellers. Situation analysis: behavioral survey. Results & discussions. Report. Sudan National AIDS Control Program; 2004.
100. McCarthy MC, Khalid IO, El Tigani A. HIV-1 infection in Juba, southern Sudan. J Med Virol 1995; 46:18-20
101. Syria Mental Health Directorate, Programme SNA. Assessment of HIV Risk and Sero-prevalence among Drug Users in Greater Damascus. Syrian Ministry of Health. UNODC. UNAIDS; 2008.
102. Orak S, Dalkilic AE, Ozbal Y. Serological investigation of HIV infections, HBsAg and syphilis in prostitutes in Elazig. Mikro-biyol Bul 1991; 25:51-56.
103. Gul U, Kilic A, Sakizligil B, Aksaray S, Bilgili S, Demirel O, et al. Magnitude of sexually transmitted infections among female sex workers in Turkey. J Eur Acad Dermatol Venereol 2008; 22:1123-1124.
104. Tiras MB, Karabacak O, Himmetoglu Ö, Yüksel S. Seropre-valence of hepatitis B and HIV infection in high-risk turkish population. Turkiye Klinikleri J Gynecol Obst 1998; 8:157-158.
105. Stulhofer A, Bozicevic I. HIV bio-behavioural survey among FSWs in Aden, Yemen, 2008. 2008.
106. Al-Serouri AW. Assessment of knowledge, attitudes and beliefs about HIV/AIDS among young people residing in high risk communities in Aden governatore, Republic of Yemen. Society for the Development of Women & Children (SOUL), Education, Health, Welfare. United Nations Children's Fund. Yemen Country Office. HIV/AIDS Project; 2005.
107. WHO, UNICEF, UNAIDS. Yemen. Epidemiological Facts Sheets on HIV/AIDS and Sexually Transmitted Infections. 2006.
108. Al-Qadhi H. A Silent Threat in Yemen: Confronting HIV/AIDS Choices. United Nations Development Programme; 2001.
109. Pisani E, Lazzari S, Walker N, Schwartlander B. HIV surveillance: a global perspective. J Acquir Immune Defic Syndr 2003; 32 (Suppl 1):S3-S11.
110. Aceijas C, Friedman SR, Cooper HL, Wiessing L, Stimson GV, Hickman M. Estimates of injecting drug users at the national and local level in developing and transitional countries, and gender and age distribution. Sex Transm Infect 2006; 82 (Suppl 3):iii10-iii17.
111. UNODC. United Nations Office on Drugs and Crime (2005). World Drug Report 2005.
112. Razzaghi EM, Movaghar AR, Green TC, Khoshnood K. Profiles of risk: a qualitative study of injecting drug users in Tehran, Iran. Harm Reduct J 2006; 3:12.
113. Gheiratmand R, Navipour R, Mohebbi MR, Mallik AK. Uncertainty on the number of HIV/AIDS patients: our experience in Iran. Sex Transm Infect 2005; 81:279-280.
114. Razzaghi E, Rahimi A, Hosseini M, Madani S. Rapid Situation Assessment (RSA) of Drug Abuse in Iran. Tehran: Prevention Department, State Welfare Organization, Ministry of Health, I.R. of Iran and United Nations International Drug Control Program; 1999.
115. Wodak A. Report to WHO/EMRO regarding control of HIV among and from injecting drug users in the IR Iran. Unpublished 1997.
116. Ghys PD, Bazant W, Monteiro MG, Calvani S, Lazzari S. The epidemics of injecting drug use and HIV in Asia. AIDS 2001; 15 (Suppl 5):S91-S99.
117. Lau JT, Thomas J, Lin CK. HIV-related behaviours among voluntary blood donors in Hong Kong. AIDS Care 2002; 14:481-492.
118. Young RM, Meyer IH. The trouble with 'MSM' and 'WSW': erasure of the sexual-minority person in public health discourse. Am J Public Health 2005; 95:1144-1149.
119. McFarland W, Caceres CF. HIV surveillance among men who have sex with men. AIDS 2001; 15 (Suppl 3):S23-S32.
120. UNAIDS. Epidemiological software and tools. http://www. unaids.org/en/KnowledgeCentre/HIVData/Epidemiology/epi- software2007.asp. 2008.
121. Mercer CH, Hart GJ, Johnson AM, Cassell JA. Behaviourally bisexual men as a bridge population for HIV and sexually transmitted infections? Evidence from a national probability survey. Int J STD AIDS 2009; 20:87-94.
122. Collumbien M, Qureshi AA, Mayhew SH, Rizvi N, Rabbani A, Rolfe B, et al. Understanding the context of male and trans-gender sex work using peer ethnography. Sex Transm Infect 2009; 85 (Suppl 2):ii3-ii7.
123. Rajabali A, Khan S, Warraich HJ, Khanani MR, Ali SH. HIV and homosexuality in Pakistan. Lancet Infect Dis 2008; 8:511-515.
124. Jenkins C, Robalino DA. HIV in the Middle East and North Africa: the cost of inaction. Orientations in Development Series, World Bank; 2003.
125. Schmitt A, Sofer J. Sexuality and Eroticism Among Males in Moslem Countries. In: New York: Harrington Park Press; 1992.
126. El-SayedN,AbdallahM,Abdel MobdyA,Abdel SattarA, Aoun E, Beths F, et al. Evaluation of Selected Reproductive Health Infections in Various Egyptian Population Groups in Greater Cairo. MOHP, IMPACT/FHI/USAID; 2002.
127. Hsairi M, Ben Abdallah S. Analyse de la situation de vulnér- abilité vis-à-vis de l'infection à VIH des hommes ayant des relations sexuelles avec des hommes. Rapport Final, version abrégée. 2007.
128. Hermez J, Aaraj E, Dewachi O, Chemaly N. HIV/AIDS prevention among vulnerable groups in Beirut, Lebanon. Powerpoint presentation.
129. Khan OA, Hyder AA. HIV/AIDS among men who have sex with men in Pakistan. Sex Health Exch 1998:12-13, 15.
130. Elrashied S. Prevalence, knowledge and related risky sexual behaviours of HIV/AIDS among receptive men who have sex with men (MSM) in Khartoum State, Sudan, 2005. Abstract TUPE0509. XVI International AIDS Conference; 13-18 August 2006; Toronto.
131. International HIV/AIDS Alliance. Spreading the word. http://www. aidsalliance.org/sw50794.asp. [accessed 12 January 2007]
132. El-Sayed N, Darwish A, El-Geeneidy M, Mehrez M. Knowledge, attitude, and practice of homosexuals regarding HIV in Egypt. Egypt: National AIDS Program, Ministry of Health and Population; 1994.
133. Elrashied SM. Generating Strategic Information and assessing HIV/AIDS Knowledge, Attitude and Behaviour and Practices as well as Prevalence of HIV1 among MSM in Khartoum State, 2005. A draft report subitted to Sudan National AIDS Control Programme. Khartoum, Sudan: Together Against AIDS Organization (TAG); 2006.
134. Chaouki N, Bosch FX, Munoz N, Meijer CJ, El Gueddari B, El Ghazi A, et al. The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer 1998; 75:546-554.
135. Blanchard JF, Khan A, Bokhari A. Variations in the population size, distribution and client volume among female sex workers in seven cities of Pakistan. Sex Transm Infect 2008; 84 (Suppl 2):ii24-ii27
136. SNAP/UNICEF/UNAIDS. Baseline study on knowledge, attitudes, and practices on sexual behaviors and HIV/AIDS prevention amongst young people in selected states in Sudan. HIV/AIDS KAPB Report. Projects and Research Department (AFROCENTER Group). 2005.
137. Ahmed SM. Antenatal. Situation Analysis-Behavioral Survey. Results & Discussions. Report. Sudan National AIDS Control Program. 2004.
138. Ahmed SM. Tea Sellers. Situation Analysis-Behavioral Survey. Results & Discussions. Report. Sudan National AIDS Control Program. 2004.
139. Vandepitte J, Lyerla R, Dallabetta G, Crabbe F, Alary M, Buve A. Estimates of the number of female sex workers in different regions of the world. Sex Transm Infect 2006; 82 (Suppl 3):iii18-iii25. (Pubitemid 43901607)
140. Blanchard JF, HalliS,Ramesh BM, BhattacharjeeP,Washington RG, O'Neil J, et al. Variability in the sexual structure in a rural Indian setting: implications for HIV prevention strategies. Sex Transm Infect 2007; 83 (Suppl 1):i30-i36.
141. Indonesia Ministry of Health. National estimates of adult HIV infection, Indonesia. Workshop report. 2002
142. WHO. Regional Office for the Western Pacific. Consensus report on STI, HIV, and AIDS epidemiology, Malaysia. 1999.
143. Morison L, Weiss HA, Buve A, Carael M, Abega SC, Kaona F, et al. Commercial sex and the spread of HIV in four cities in sub-Saharan Africa. AIDS 2001; 15 (Suppl 4):S61-S69. (Pubitemid 32913005)
144. Action Aid Afghanistan. HIV AIDS in Afghanistan. A study on knowledge, attitude, behavior, and practice in high risk and vulnerable groups in Afghanistan. 2006.
145. Genc M, Gunes G, Karaoglu L, Egri M. AIDS awareness and knowledge among married women livingin Malatya (Turkey): implications for province-based prevention programs. New Microbiol 2005; 28:161-164.
146. ACCORD. Socio Economic Research on HIV/AIDS Prevention among Informal Sex Workers. Agency for Co-operation and Research in Development. Federal Ministry of Health, Sudan National AIDS Control Program, and the World Health Organization 2005
147. Syria National AIDS Programme. HIV/AIDS Female Sex Workers KABP Survey in Syria. 2004.
148. Lau JT, Tsui HY, Siah PC, Zhang KL. A study on female sex workers in southern China (Shenzhen): HIV-related knowledge, condom use and STD history. AIDS Care 2002; 14:219-233.
149. Strathdee SA, Lozada R, Semple SJ, Orozovich P, Pu M, Staines-Orozco H, et al. Characteristics of female sex workers with US clients in two Mexico-US border cities. Sex Transm Dis 2008; 35:263-268. (Pubitemid 351619533)
150. Elmore-Meegan M, Conroy RM, Agala CB. Sex workers in Kenya, numbers of clients and associated risks: an exploratory survey. Reprod Health Matters 2004; 12:50-57.
151. Wilson D, Chiroro P, Lavelle S, Mutero C. Sex worker, client sex behaviour and condom use in Harare, Zimbabwe. AIDS Care 1989; 1:269-280.
152. Ati HA. HIV/AIDS/STIs Social and Geographical Mapping of Prisoners, Tea Sellers and Commercial Sex Workers in Port Sudan Town, Red Sea State. Draft 2. Sudan: Ockenden International; 2005
153. Sudan National AIDS Control Program. Sex sellers situation analysis & behavioral survey: results and discussions. Khartoum; 2004.
154. Rehan N. Profile of men suffering from sexually transmitted infections in Pakistan. J Pak Med Assoc 2006; 56: S60-S65.
155. IsmailSO, AhmedHJ, GrillnerL,HederstedtB,IssaA,Bygdeman SM. Sexually transmitted diseases in men in Mogadishu, Somalia. Int J STD AIDS 1990; 1:102-106.
156. Omer EE, Ali MH, Taha OM, Ahmed MA, Abbaro SA. Sexually transmitted diseases in Sudanese males. Trop Doct 1982; 12:208-210.
157. Zamani S, Ichikawa S, Nassirimanesh B, Vazirian M, Ichikawa K, Gouya MM, et al. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran. Int J Drug Policy 2007; 18:359-363.
158. World Bank. HIV/AIDS in Afghanistan. 2006.
159. Todd CS, others a. Prevalence of HIV, Hepatitis C, Hepatitis B, and Associated Risk Behaviors among Injection Drug Users in Kabul, Afghanistan. Submitted for publication. 2007.
160. Tehrani FR, Malek-Afzalip H. Knowledge, attitudes and practices concerning HIV/AIDS among Iranian at-risk sub-populations. Eastern Mediterranean Health Journal 2008; 14.
161. Mayhew S, Collumbien M, Qureshi A, Platt L, Rafiq N, Faisel A, et al. Protecting the unprotected: mixed-method research on drug use, sex work and rights in Pakistan's fight against HIV/AIDS. Sex Transm Infect 2009; 85 (Suppl 2):ii31-ii36.
162. El-Saharty S, Ali O. An effective well coordinated response to HIV in Djibouti. World Bank Global HIV/AIDS Program. Geneva: World Bank; 2006.
163. Ryan S. Travel Report Summary. Kabul, Afghanistan. Joint United Nations Programme on HIV/AIDS. Geneva: UN; 2006.
164. Agha S. Potential for HIV transmission among truck drivers in Pakistan. Aids 2000; 14:2404-2406.
165. Faisel A, Cleland J. Study of the sexual behaviours and prevalence of STIs among migrant men in Lahore, Pakistan. Arjumand and Associates. Centre for Population Studies, London School of Hygiene and Tropical Medicine; 2006.
166. Faisel A, Cleland J. Migrant men: a priority for HIV control in Pakistan? Sex Transm Infect 2006; 82:307-310.
167. Aidaoui M, Bouzbid S, Laouar M. Seroprevalence of HIV infection in pregnant women in the Annaba region (Algeria). Rev Epidemiol Sante Publique 2008; 56:261-266.
168. Bennani A, Alami K. Surveillance sentinelle VIH, résultats 2005 et tendances de la séroprévalence du VIH. Ministry of health. Morocco: UNAIDS; 2006.
169. Ahmed AJ, Hassan N, Pasha O, Fisher-Hoch S, McCormick JB, Luby SP. Prevalence of STDs among long-distance truck drivers in Pakistan. Proceedings of the Conference on HIV Surveillance; Karachi, Pakistan; 1995.
170. Mujeeb SA, Hafeez A. Prevalence and pattern of HIV infection in Karachi. J Pak Med Assoc 1993; 43:2-4.
171. Burans JP, McCarthy M, el Tayeb SM, el Tigani A, George J, Abu-Elyazeed R, et al. Serosurvey of prevalence of human immunodeficiency virus amongst high risk groups in Port Sudan, Sudan. East Afr Med J 1990; 67:650-655.
172. Farah MS, Hussein S. HIV Prevalence, Knowledge, Attitude, Practices and Risk Factors among Truck Drivers in Karthoum State. 2006.
173. McCarthy MC, Hyams KC, el-Tigani el-Hag A, el-Dabi MA, el-Sadig el-Tayeb M, Khalid IO, et al. HIV-1 and hepatitis B transmission in Sudan. AIDS 1989; 3:725-729.
174. Ahmed SM. Military. Situation Analysis-Behavioral Survey. Results & Discussions. Report. Sudan National AIDS Control Program. 2004
175. Sudan National AIDS Program, The New Sudan National AIDS Council, UNAIDS. Scaling-up HIV/AIDS Response in Sudan. National Consultation on the Road towards Universal Access to Prevention, Treatment, Care and Support. 2006.
176. Botros BA, Aliyev Q, Saad M, Monteville M, Michael A, Nasibov Z, et al. HIV prevalence and risk behaviours among international truck drivers in Azerbaijan. In: 17th European Congress of Clinical Microbiology and Infectious Diseases. ICC, Munich, Germany; 2007.
177. O'Grady M. WFP Consultant Visit to Djibouti Report. 30 July 2004.
178. Ahmed SM. Truck Drivers. Situation Analysis-Behavioral Survey. Results & Discussions. Report. Sudan National AIDS Control Program. 2004
179. Sudan National HIV/AIDS Control Program. HIV/AIDS/STIs Prevalence, Knowledge, Attitude, Practices and Risk Factors among University Students and Military Personnel. Sudan: Federal Ministry of Health. Khartoum; 2004.
180. Todd CS, Ahmadzai M, Atiqzai F, Siddiqui H, Azfar P, Miller S, et al. Seroprevalence & correlates of HIV, syphilis, & hepatitis B & C infection among antenatal patients & testing practices & knowledge among
181. Todd CS, Ahmadzai M, Atiqzai F, Miller S, Smith JM, Ghazanfar SA, et al. Seroprevalence and correlates of HIV, syphilis, and hepatitis B and C virus among intrapartum patients in Kabul, Afghanistan. BMC Infect Dis 2008; 8:119.
182. Dupire B, Abawi AK, GanteaumeC, Lam T, Truze P, Martet G. Establishment of a blood transfusion center at Kabul (Afghanistan). Sante 1999; 9:18-22.
183. Afghanistan Central Blood Bank. Report of Testing of Blood Donors from March-December 2006. Kabul, Afghanistan: Ministry of Public Health 2006.
184. Maslin J, Rogier C, Berger F, Khamil MA, Mattera D, Grandadam M, et al. Epidemiology and genetic characterization of HIV-1 isolates in the general population of Djibouti (Horn of Africa). J Acquir Immune Defic Syndr 2005; 39:129-132.
185. Ministère de La Santé de Djibouti/Association Internationale de Développement. Epidémie a VIH/SIDA/IST en République de Djibouti; Tome I: Analyse de la Situation et Analyse de la Réponse Nationale. Décembre 2002. 2002.
186. Surveillance des infections à VIH et de la syphilis chez les femmes enceintes vues dans 8 centres de consultations pré-natales dans le district de Djibouti. 2002. 2002.
187. Dray X, Dray-Spira R, Bronstein JA, Mattera D. Prevalences of HIV, hepatitis B and hepatitis C in blood donors in the Republic of Djibouti. Med Trop (Mars) 2005; 65:39-42.
188. Massenet D, Bouh A. Aspects of blood transfusion in Djibouti. Med Trop (Mars) 1997; 57:202-205.
189. Constantine NT, Sheba MF, Watts DM, Farid Z, Kamal M. HIV infection in Egypt: a two and a half year surveillance. J Trop Med Hyg 1990; 93:146-150.
190. Kandela P. Arab nations: attitudes to AIDS. Lancet 1993; 341:884-885.
191. Quinti I, Renganathan E, El Ghazzawi E, Divizia M, Sawaf G, Awad S, et al. Seroprevalence of HIV and HCV infections in Alexandria, Egypt. Zentralbl Bakteriol 1995; 283:239-244.
192. Amini S, Mahmoodi MF, Andalibi S, Solati AA. Seroepide-miology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study. J Trop Med Hyg 1993; 96:277-287.
193. Massarrat MS, Tahaghoghi-Mehrizi S. Iranian national health survey: a brief report. Arch Iranian Med 2002; 2:73-79
194. Iran Ministry of Health. Treatment and medical education. Islamic Republic of Iran HIV/AIDS situation and response analysis. 2006.
195. Sharifi-Mood B, Keikha F. Seroprevalence of human immunodeficiency virus (HIV) in pregnant women in Zahedan, Southeastern Iran. J Res Med Sci 2008; 13:186-188
196. WHO/EMRO. HIV/AIDS Surveillance in Low Level and Concentrated HIV Epidemics. A technical guide for countries in the WHO Eastern Mediterranean Region; 2007.
197. Pourshams A, Malekzadeh R, Monavvari A, Akbari MR, Mohamadkhani A, Yarahmadi S, et al. Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors. J Gastroenterol Hepatol 2005; 20:229-233.
198. Rezvan H, Abolghassemi H, Kafiabad SA. Transfusion-transmitted infections among multitransfused patients in Iran: a review. Transfus Med 2007; 17:425-433.
199. Khedmat H, Fallahian F, Abolghasemi H, Alavian SM, Haji-beigi B, Miri SM, et al. Seroepidemiologic study of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and syphilis infections in Iranian blood donors. Pak J Biol Sci 2007; 10:4461-4466.
200. Al Katheeb MS, Tarawneh MS, Awidi AS. Antibodies to HIV in Jordanian blood donors and patients with congenital bleeding disorders. IV International Conference on AIDS; Stockholm; 1988; abstract 5003.
201. AmeenR, Sanad N, Al-Shemmari S, Siddique I, Chowdhury RI, Al-Hamdan S, et al. Prevalence of viral markers among first-time Arab blood donors in Kuwait. Transfusion 2005; 45: 1973-1980.
202. Libya National Center for the Prevention of and Control of Infectious Diseases. Results of the National Seroprevalence Survey. 2005.
203. El-Gadi S, Abudher A, Sammud M. HIV-related knowledge and stigma among high school students in Libya. Int J STD AIDS 2008; 19:178-183.
204. WHO. HIV/AIDS epidemiological surveillance report for the WHO African region 2002 update. 2002.
205. Elharti E, Zidouh A, Mengad R, Bennani O, Elaouad R. Monitoring HIV through sentinel surveillance in Morocco. East Mediterr Health J 2002; 8:141-149.
206. Morocco Ministry of Health. Implementation of the declaration of commitment on HIV/AIDS. 2006 National Report. Morocco: Morocco Ministry of Health; 2006.
207. Elmir E, Nadia S, Ouafae B, Rajae M, Amina S, Rajae el A, et al. HIV epidemiology in Morocco: a nine-year survey (1991-1999). Int J STD AIDS 2002; 13:839-842.
208. Elharti E. HIV epidemiology in Morocco: a nine-year survey (1991-1999). Int J STD AIDS 2002; 13:839-842.
209. Mujeeb SA, Khanani MR, Khursheed T, Siddiqui A. Prevalence of HIV-infection among blood donors. J Pak Med Assoc 1991; 41:253-254.
210. Mujeeb SA, Aamir K, Mehmood K. Seroprevalence of HBV, HCV and HIV infections among college going first time voluntary blood donors. J Pak Med Assoc 2006; 56:S24-S25.
211. Abdul Mujeeb S, Aamir K, Mehmood K. Seroprevalence of HBV, HCV and HIV infections among college going first time voluntary blood donors. J Pak Med Assoc 2000; 50:269-270.
212. Sultan F, Mehmood T, Mahmood MT. Infectious pathogens in volunteer and replacement blood donors in Pakistan: a ten-year experience. Int J Infect Dis 2007; 11:407-412.
213. Kayani N, Sheikh A, Khan A, Mithani C, Khurshid M. A view of HIV-I infection in Karachi. J Pak Med Assoc 1994; 44:8-11.
214. Kakepoto GN, Bhally HS, Khaliq G, Kayani N, Burney IA, Siddiqui T, et al. Epidemiology of blood-borne viruses: a study of healthy blood donors in Southern Pakistan. Southeast Asian J Trop Med Public Health 1996; 27:703-706
215. Pakistan National Institute of Health. National AIDS Control Program Report. Islamabad: Government of Pakistan; 1992
216. Pakistan National Institute of Health. National AIDS Control Program Report. Islamabad: Government of Pakistan; 1995.
217. Abdul Mujeeb S, Hashmi MR. A study of HIV-antibody in sera of blood donors and people at risk. J Pak Med Assoc 1988; 38:221-222.
218. State of Qatar. Report on the country progress indicators towards implementing the declaraion of commitment on HIV. 2008.
219. El-Hazmi MM. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. Saudi Med J 2004; 25:26-33.
220. Alamawi S, Abutaleb A, Qasem L, Masoud S, Memish Z, Al Khairy K, et al. HIV-1 p24 antigen testing in blood banks: results from Saudi Arabia. Br J Biomed Sci 2003; 60:102-104.
221. Al Rasheed AM, Fairclough D, Abu Al Sand, Osoba AO. Screening for HIV antibodies among blood donors at Riyadh Armed Forces Hospital. VI International Conference on AIDS; Stockholm; 1988; abstract 5001.
222. WHO. The 2004 First National Second Generation HIV/AIDS/STI Sentinel Surveillance Survey, Somalia. A Technical Report. Geneva: WHO; 2004.
223. Somaliland Ministry of Health and Labour. Somaliland 2007 HIV/syphilis seroprevalence survey. A technical report. Ministry of Health and Labour. In collaboration with the World Health Organization, UNAIDS, UNICEF/GFATM, and SOL-NAC. 2007.
224. WHO. The 2004 First National Second Generation HIV/AIDS/STI Sentinel Surveillance Survey, Central South, Somalia, A Technical Report. 2004.
225. WHO. The 2004 First National Second Generation HIV/AIDS/STI Sentinel Surveillance Survey, Puntland, Somalia, A Technical Report. 2004.
226. UNHCR. HIV Sentinel Surveillance among Antenatal Clients and STI patients. Dadaab Refugee Camps, Kenya. United Nations High Commissioner for Refugees. 2006/07.
227. UNHCR. National AIDS and Sexually Transmitted Control Programme. HIV sentinel surveillance in Dadaab refugee camps. Nairobi: UNHCR; 2003.
228. UNHCR. National AIDS and Sexually Transmitted Control Programme. Sentinel surveillance report Dadaab refugee camps, Kenya January-May 2005. UNHCR: Nairobi; 2005.
229. WHO. WHO Somalia Statististic Report 2003. Geneva: WHO; 2003.
230. Kulane A, Hilowle AA, Hassan AA, Thorstensson R. Prevalence of HIV, HTLV I/II and HBV infections during long lasting civil conflicts in Somalia. Int Conf AIDS 2000:13
231. Sudan National AIDS Program. Update on the HIV Situation in Sudan. Powerpoint presenation. 2008
232. Sudan Ministry of Health. 2005 ANC sentinel sites results. Khartoum. 2006.
233. Sudan National AIDS Control Programme. National Policy on HIV/AIDS. 2005. 2005.
234. Kaiser R, Kedamo T, Lane J, Kessia G, Downing R, Handzel T, et al. HIV, syphilis, herpes simplex virus 2, and behavioral surveillance among conflict-affected populations in Yei and Rumbek, southern Sudan. AIDS 2006; 20:942-944.
235. Gutbi OS-A, Eldin AMG. Women Tea-Sellers in Khartoum and HIV/AIDS: Surviving Against the Odds. Khartoum, Sudan; 2006.
236. Sudan National AIDS/STIs Program. 2007 ANC HIV Sentinel Sero-survey, Technical Report, Federal Ministry of Health, Preventive Medicine Directorate, Draft. 2008
237. Sudan National AIDS Control Program. Sentinel Sero-Survai-lance-2005 Data. Annual News Letter. 2005.
238. UNHCR. Kakuma Refugee Camp-Refugees and Host Nationals. Great Lakes Initiative on HIV/AIDS. HIV Sentinel Surveillance among Conflict Affected Populations. United Nations High Commissioner for Refugees. 2006/07.
239. IRC. CDC. Kakuma refugee camp sentinel surveillance report. Nairobi. 2002.
240. Sudan National AIDS Programme, UNAIDS. HIV/AIDS Integrated Report North Sudan 2004-2005 (Draft). With United Nations General Assembly Special Session on HIV/AIDS Declaration of Commitment. 2006.
241. The New Sudan AIDS Council (NSNAC). UNAIDS. HIV/AIDS Integrated Report South Sudan 2004-2005. United Nations General Assembly Special Session on HIV/AIDS Declaration of Commitment 2006.
242. Southern Sudan AIDS Commission. Southern Sudan ANC Sentinel Surveillance Data. US Centers for Disease Control and Prevention (CDC), Sudan, in collaboration with Southern Sudan AIDS Commission. 2007.
243. UNAIDS. Epidemiological country fact sheet. Sudan 2000. 2000.
244. Gassmelseed DE, Nasr AM, Homeida SM, Elsheikh MA, Adam I. Prevalence of HIV infection among pregnant women of the central Sudan. J Med Virol 2006; 78:1269-1270.
245. Hashim MS, Salih MA, el Hag AA, Karrar ZA, Osman EM, el-Shiekh FS, et al. AIDS and HIV infection in Sudanese children: a clinical and epidemiological study. AIDS Patient Care STDS 1997; 11:331-337.
246. Aiding refugees in the aftermath of civil war. Country focus: Sudan. AIDS Anal Afr 1996; 6:3.
247. Afsar I, Gungor S, Sener AG, Yurtsever SG. The prevalence of HBV, HCV and HIV infections among blood donors in Izmir, Turkey. Indian J Med Microbiol 2008; 26:288-289.
248. Coskun O,Gul C, ErdemH, Bedir O, Eyigun CP. Prevalence of HIV and syphilis among Turkish blood donors. Ann Saudi Med 2008; 28:470.
249. Arabaci F, Sahin HA, Sahin I, Kartal S. Kan donörlerinde HBV, HCV, HIV ve VDRL seropozitifligi. Klimik Derg 2003; 16:18-20.
250. Yassin K, Awad R, Tebi AJ, Queder A, Laaser U. A zero prevalence of anti-HIV in blood donors in Gaza: how can it be sustained? AIDS 2001; 15:936-937.
251. Maayan S, Shinar E, Aefani M, Soughayer M, Alkhoudary R, Barshany S, et al. HIV-1 prevalence among Israeli and Palestinian blood donors. AIDS 1994; 8:133-134.
252. Yemen National AIDS Control Programme. Ministry of Public Health Yemen. AIDS/HIV surveillance report, fourth quarter 1998. 1998.
253. Yemen National AIDS Control Programme. Ministry of Public Health Yemen. AIDS/HIV surveillance report, fourth quarter 2001. 2001.
254. Jurjus AR, Kahhaleh J, National AIDS Program, Organization-EMRO WH. Knowledge, Attitudes, Beliefs, and Practices of the Lebanese Concerning HIV/AIDS. Beirut, Lebanon; 2004.
255. Hammouda D, Munoz N, Herrero R, Arslan A, Bouhadef A, Oublil M, et al. Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors. Int J Cancer 2005; 113:483-489.
256. Naffa S. Jordanian Women: Past and Present. 2004.
257. Chaleby K. Women of polygamous marriages in an inpatient psychiatric service in Kuwait. J Nerv Ment Dis 1985; 173:56-58.
258. Zargooshi J. Characteristics of gonorrhoea in Kermanshah, Iran. Sex Transm Infect 2002; 78:460-461.
259. Abu-Raddad LJ. Multiple discussions with members of National AIDS Programs in MENA. 2006-2009.
260. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005; 2:e298.
261. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007; 369:643-656.
262. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007; 369:657-666.
263. Weiss HA, Halperin D, Bailey RC, Hayes RJ, Schmid G, Hankins CA. Male circumcision for HIV prevention: from evidence to action? AIDS 2008; 22:567-574. (Pubitemid 351640589)
264. UNHCR. HIV Behavioural Surveillance Survey Juba Municipality, South Sudan. United Nations High Commissioner for Refugees; 2007.
265. Alsallaq RA, Cash B, Weiss HA, Longini IM, Omer SB, Wawer MJ, et al. Quantitative assessment of the role of male circumcision in HIV epidemiology at the population level. Epidemics (in press).
266. Bailey RC, Neema S, Othieno R. Sexual behaviors and other HIV risk factors in circumcised and uncircumcised men in Uganda. J Acquir Immune Defic Syndr 1999; 22:294-301.
267. Rakwar J, Lavreys L, Thompson ML, Jackson D, Bwayo J, Hassanali S, et al. Cofactors for the acquisition of HIV-1 among heterosexual men: prospective cohort study of trucking company workers in Kenya. AIDS 1999; 13:607-614.
268. Isiugo-Abanihe UC. Extramarital relations and perceptions of HIV/AIDS in Nigeria. Health Transit Rev 1994; 4:111-125.
269. Biaya TK. Les plaisirs de la ville: Masculinité, sexualité et féminité à Dakar (1997-2000). Afr Stud Rev 2001:71-85.
270. Gilbert SS. The influence of Islam on AIDS prevention among Senegalese university students. AIDS Educ Prev 2008; 20:399-407.
271. Shirazi KK, Morowatisharifabad MA. Religiosity and determinants of safe sex in Iranian nonmedical male students. J Relig Health 2009; 48:29-36.
272. Kengeya-Kayondo JF, Kamali A, Nunn AJ, Ruberantwari A, Wagner HU, Mulder DW. Incidence of HIV-1 infection in adults and socio-demographic characteristics of seroconver-ters in a rural population in Uganda: 1990-1994. Int J Epidemiol 1996; 25:1077-1082.
273. Malamba SS, Wagner HU, Maude G, Okongo M, Nunn AJ, Kengeya-Kayondo JF, et al. Risk factors for HIV-1 infection in adults in a rural Ugandan community: a case-control study. AIDS 1994; 8:253-257.
274. Gray RH, Kiwanuka N, Quinn TC, Sewankambo NK, Serwad-da D, Mangen FW, et al. Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. Rakai Project Team. AIDS 2000; 14:2371-2381.
275. Mbulaiteye SM, Ruberantwari A, Nakiyingi JS, Carpenter LM, Kamali A, Whitworth JA. Alcohol and HIV: a study among sexually active adults in rural southwest Uganda. Int J Epidemiol 2000; 29:911-915.
276. Bwayo J, Plummer F, Omari M, Mutere A, Moses S, Ndinya-Achola J, et al. Human immunodeficiency virus infection in long-distance truck drivers in east Africa. Arch Intern Med 1994; 154:1391-1396.
277. Nunn AJ, Kengeya-Kayondo JF, Malamba SS, Seeley JA, Mulder DW. Risk factors for HIV-1 infection in adults in a rural Ugandan community: a population study. AIDS 1994; 8:81-86.
278. Abebe Y, Schaap A, Mamo G, Negussie A, Darimo B, Wolday D, et al. HIV prevalence in 72 000 urban and rural male army recruits, Ethiopia. AIDS 2003; 17:1835-1840. (Pubitemid 37000102)
279. Drain PK, Smith JS, Hughes JP, Halperin DT, Holmes KK. Correlates of national HIV seroprevalence: an ecologic analysis of 122 developing countries. J Acquir Immune Defic Syndr 2004; 35:407-420.
280. MedaN,NdoyeI, M'BoupS,WadeA,NdiayeS,NiangC,etal. Low and stable HIV infection rates in Senegal: natural course of the epidemic or evidence for success of prevention? AIDS 1999; 13:1397-1405.
281. Kagee A, Toefy Y, Simbayi L, Kalichman S. HIV prevalence in three predominantly Muslim residential areas in the Cape Town metropole. S Afr Med J 2005; 95:512-516.
282. Hargrove J. Migration, Mines and Mores: The HIV epidemic in Southern Africa. Inaugural Address. Stellenbosch University; 2007.
283. Pickthall M. The Meaning of the Glorious Qur'an. Hyderabad, India. Chapters and Verses; 17:32, 26:165-166, 5:90. 1930.
284. Kaljee LM, Genberg BL, Minh TT, Tho LH, Thoa LT, Stanton B. Alcohol use and HIV risk behaviors among rural adolescents in Khanh Hoa Province Viet Nam. Health Educ Res 2005; 20:71-80.
285. Fisher JC, Bang H, Kapiga SH. The association between HIV infection and alcohol use: a systematic review and meta-analysis of African studies. Sex Transm Dis 2007; 34:856-863.
286. Huff B. Male circumcision: cutting the risk? American Foundation for AIDS Research; 2000.
287. Alrajhi AA, Halim MA, Al-Abdely HM. Mode of transmission of HIV-1 in Saudi Arabia. AIDS 2004; 18:1478-1480.
288. Ramezani A, Mohraz M, Gachkar L. Epidemiologic situation of human immunodeficiency virus (HIV/AIDS patients) in a private clinic in Tehran, Iran. Arch Iran Med 2006; 9:315-318.
289. Burrows D,Wodak A, WHO. Harm Reductionin Iran. Issues in national scale-up. Report for World Health Organization. 2005.
290. Hallett TB, Gregson S, Lewis JJ, Lopman BA, Garnett GP. Behaviour change in generalised HIV epidemics: impact of reducing cross-generational sex and delaying age at sexual debut. Sex Transm Infect 2007; 83 (Suppl 1):i50-i54.
291. Sy T, Jamal MM. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci 2006; 3:41-46.
292. United Nations Programme on AIDS. AIDS Epidemic Update 2005. Geneva: WHO 2005.
293. United Nations Office for Drug Control and Crime Prevention. United Nations Office on AIDS. Baseline study of the relationship between injecting drug use, HIV and hepatitis C among male injecting drug users in Lahore. Islamabad: UNDCP and UNAIDS 1999.
294. Agha A, Parviz S, Younus M, Fatmi Z. Socio-economic and demographic factors associated with injecting drug use among drug users in Karachi, Pakistan. J Pak Med Assoc 2003; 53:511-516.
295. Baqi S, Shah SA, Baig MA, Mujeeb SA, Memon A. Seropre-valence of HIV, HBV and syphilis and associated risk behaviours in male transvestites (Hijras) in Karachi, Pakistan. J Pak Med Assoc 2006; 56:S17-S21.
296. Pisani E, Girault P, Gultom M, Sukartini N, Kumalawati J, Jazan S, et al. HIV, syphilis infection, and sexual practices among transgenders, male sex workers, and other men who have sex with men in Jakarta, Indonesia. Sex Transm Infect 2004; 80:536-540.
297. Commission on AIDS in Asia. Redfining AIDS in Asia. Crafting an Effective Response. Report of the Commission on AIDS in Asia. Presented to Mr. Ban Ki-moon, UN Secretary General. Oxford University Press 2008.
298. World Bank. Preventing HIV/AIDS in the Middle East and north Africa: a window of opportunity to act. Orientations in Development Series, World Bank; 2005.
299. Buse K, Lalji N, Mayhew SH, Imran M, Hawkes SJ. Political feasibility of scaling-up five evidence-informed HIV interventions in Pakistan: a policy analysis. Sex Transm Infect 2009; 85 (Suppl 2):ii37-ii42.
300. Jordan National AIDS Program. National HIV/AIDS Strategy for Jordan 2005-2009. Draft. 2005.
301. Razzaghi E, Nassirimanesh B, Afshar P, Ohiri K, Claeson M, Power R. HIV/AIDS harm reduction in Iran. Lancet 2006; 368:434-435.
302. Vazirian M, Nassirimanesh B, Zamani S, Ono-Kihara M, Kihara M, Ravari SM, et al. Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: a cross-sectional study. Harm Reduct J 2005; 2:19.
303. Pisani E, Garnett GP, Grassly NC, Brown T, Stover J, Hankins C, et al. Back to basics in HIV prevention: focus on exposure. BMJ 2003; 326:1384-1387.
304. Aden AS, Dahlgren L, Guerra R. Experiences against HIV/AIDS/STDS of Somalis in exile in Gothenburg, Sweden. Ann Ig 2004; 16:141-155.
305. Lazarus JV, Himedan HM, Ostergaard LR, Liljestrand J. HIV/AIDS knowledge and condom use among Somali and Sudanese immigrants in Denmark. Scand J Public Health 2006; 34:92-99.